Sino Biopharmaceutical

(OTC) SBHMY

Current Price$11.27

Market Cap$10.05B

Since IPO (2017)+47%

5 Year-43%

1 Year+21%

1 Month-21%

Sino Biopharmaceutical Financials at a Glance

Market Cap

$10.05B

Revenue (TTM)

CN¥30.57B

Net Income (TTM)

CN¥3.87B

EPS (TTM)

$0.35

P/E Ratio

31.76

Dividend

$0.23

Beta (Volatility)

0.04 (Low)

Dividend

$0.23

Beta (Volatility)

0.04 (Low)

Price

$11.27

Volume

Open

$11.27

Price

$11.27

Volume

Open

$11.27

Previous Close

$11.27

Daily Range

$11.27 - $11.27

52-Week Range

$9.48 - $20.16

Estimated Earnings Date

Mar 18, 2026

Dividend

$0.23

Beta (Volatility)

0.04 (Low)

Price

$11.27

Volume

Open

$11.27

Previous Close

$11.27

Daily Range

$11.27 - $11.27

52-Week Range

$9.48 - $20.16

Estimated Earnings Date

Mar 18, 2026

SBHMY News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Sino Biopharmaceutical

Industry

Pharmaceuticals

Sector

Health Care

Employees

21,435

CEO

S Y Tse

Website

www.sinobiopharm.com

Headquarters

Wan Chai, HK

SBHMY Financials

Key Financial Metrics (TTM)

Gross Margin

82%

Operating Margin

22%

Net Income Margin

Return on Equity

Return on Capital

14%

Return on Assets

Earnings Yield

3.15%

Dividend Yield

2.05%

Payout Ratio

0.00%

Stock Overview

Market Cap

$10.05B

Shares Outstanding

891.82M

Volume

Avg. Volume

18.188

Financials (TTM)

Gross Profit

CN¥25.41B

Operating Income

CN¥6.63B

EBITDA

CN¥7.78B

Operating Cash Flow

CN¥9.29B

Capital Expenditure

-CN¥1.70B

Free Cash Flow

CN¥7.59B

Cash & ST Invst.

CN¥22.56B

Total Debt

CN¥16.08B

Sino Biopharmaceutical Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2025YOY CHG

Revenue

CN¥8.79B

+10.7%

Gross Profit

CN¥7.25B

+11.2%

Gross Margin

82.47%

N/A

Market Cap

$10.05B

N/A

Market Cap/Employee

$412.27K

N/A

Employees

24,379

N/A

Net Income

CN¥1.69B

+12.3%

EBITDA

CN¥1.98B

+0.1%

Quarterly Fundamentals

Name

Q2 2025YOY CHG

Total Cash

CN¥22.96B

+57.3%

Total Debt

CN¥16.07B

+64.3%

Accounts Receivable

CN¥7.87B

+58.4%

Inventory

CN¥2.26B

-4.9%

Long Term Debt

CN¥7.65B

+267.8%

Short Term Debt

CN¥8.42B

+9.3%

Return on Assets

3.08%

N/A

Return on Invested Capital

13.69%

N/A

Free Cash Flow

CN¥0.00

-100.0%

Operating Cash Flow

CN¥0.00

-100.0%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

GNMSFGenmab A/S

GNMSFGenmab A/S$249.00+0.00%

WXXWYWuXi Biologics (Cayman) Inc.

WXXWYWuXi Biologics (Cayman) Inc.$7.89+4.46%

IVBXFInnovent Biologics, Inc.

IVBXFInnovent Biologics, Inc.$9.79+2.02%

WXIBFWuXi Biologics (Cayman) Inc.

WXIBFWuXi Biologics (Cayman) Inc.$4.40+0.00%

SAUHYStraumann Holding AG

SAUHYStraumann Holding AG$11.69-1.06%

SAUHFStraumann Holding AG

SAUHFStraumann Holding AG$121.77+3.86%

ORINYOrion Oyj

ORINYOrion Oyj$39.00+2.67%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$14.80+0.05%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.59+0.04%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$77.52+0.02%

SMCISuper Micro Computer

SMCISuper Micro Computer$30.46-0.05%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$40.04-0.02%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.02-0.00%

ONDSOndas

ONDSOndas$9.33-0.05%

Questions About SBHMY

What is the current price of Sino Biopharmaceutical?

Sino Biopharmaceutical is trading at $11.27 per share.

What is the 52-week range for Sino Biopharmaceutical?

Over the past 52 weeks, Sino Biopharmaceutical has traded between $9.48 and $20.16.

How much debt does Sino Biopharmaceutical have?

As of the most recent reporting period, Sino Biopharmaceutical reported total debt of CN¥2.30B.

How much cash does Sino Biopharmaceutical have on hand?

Sino Biopharmaceutical reported CN¥1.06B in cash and cash equivalents in its most recent financial results.

What is Sino Biopharmaceutical’s dividend yield?

Sino Biopharmaceutical currently has a dividend yield of 2.05%.

Sino Biopharmaceutical

Sino Biopharmaceutical Financials at a Glance

SBHMY News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Sino Biopharmaceutical

SBHMY Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Sino Biopharmaceutical Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About SBHMY

What is the current price of Sino Biopharmaceutical?

What is the 52-week range for Sino Biopharmaceutical?

How much debt does Sino Biopharmaceutical have?

How much cash does Sino Biopharmaceutical have on hand?

What is Sino Biopharmaceutical’s dividend yield?

Premium Investing Services